Safety Alerts & Recalls
What does this mean?
This voluntary recall is not due to product safety issues. All Daytrana patches, including those in the lots listed above, can continue to be used. However, patches with a release liner that cannot be removed or patches that are damaged while being opened should not be used.
If you are or someone you care for is using Daytrana and you are concerned, please follow up with your doctor or pharmacist. You can also call Shire's Daytrana customer service line at 1-800-828-2088, option 1, if you have any problems using the patches.
If you have any other medical questions, you should contact your doctor or other healthcare provider.
Non-Safety-Related Recall of a Limited Portion of Daytrana Patches
Shire Pharmaceuticals has recalled six lots of Daytrana, a patch form of methylphenidate used to treat attention deficit hyperactivity disorder (ADHD). Shire is taking this action because some Daytrana patches may not meet their release liner removal specification. As a result, patients and caregivers could have difficulty removing the liners from the patches.
The lots numbers being recalled include: 1) Daytrana 20 mg - Lots 33988, 34174, and 34175
2) Daytrana 30 mg - Lots 33990, 33991, and 34179
No other lots of Daytrana were affected and the company does not anticipate any product shortages as a result of this recall. Methylphenidate is also sold under the other names Concerta, Daytrana, Metadate CD, Metadate ER, Methylin, Methylin ER, Ritalin, Ritalin-LA, and Ritalin-SR. This recall does not affect these other products.
For more information please visit: more information here